The data described above suggested that CDCA2 plays antiapoptotic and proliferative roles, possibly through the inactivation of the p38 MAPK pathway and the activation of the JNK/c-Jun pathway in HCC cells. The gene discussed is CDCA2; the disease is hepatocellular carcinoma.